Showing results (111-120 of 326) with videos related to

Sort By:
Pageof 33
Magnetic Resonance Imaging|January 11, 2019
Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosisPhilipp Eisele, Kristina Szabo, Anne Ebert, et al.
Therapeutic Advances in Neurological Disorders|February 17, 2018
Off-label use of IV t-PA in patients with intracranial neoplasm and cavernomaChristopher Jan Schwarzbach, Anne Ebert, Michael G Hennerici, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2013
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapyMarkus Weiler, Jonas Blaes, Stefan Pusch, et al.
Nature|July 22, 2014
A vaccine targeting mutant IDH1 induces antitumour immunityTheresa Schumacher, Lukas Bunse, Stefan Pusch, et al.
Journal for Immunotherapy of Cancer|September 22, 2025
ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancerKatharina Lindner, Saskia R Stange, Julian Benedikt Hlawatsch, et al.
Journal of Neuro-Oncology|July 17, 2016
Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastomaAnne Hertenstein, Thomas Hielscher, Oliver Menn, et al.
Nature Reviews. Neurology|May 13, 2017
Vaccine-based immunotherapeutic approaches to gliomas and beyondMichael Weller, Patrick Roth, Matthias Preusser, et al.
Nature|March 25, 2021
A vaccine targeting mutant IDH1 in newly diagnosed gliomaMichael Platten, Lukas Bunse, Antje Wick, et al.
Pageof 33